Customer Service 1 (888) 261-2693
Please enter Search keyword. Advanced Search
Home About Us Resources Archive Free Reports Market Window

Frequently Asked Questions





Q: How can I sign up to receive DailyWealth?

A: To sign up for DailyWealth – and receive a free investment report – click here.
back to top


Q: What is DailyWealth Premium?

A: In DailyWealth Premium, Steve Sjuggerud gives you access to all of the best ideas he covers... the best ideas covered by his fellow Stansberry Research analysts... AND the best ideas he finds written up in other high-quality subscription publications. Click here to read more.
 
back to top


Q: Who publishes DailyWealth?

A: DailyWealth is published by Stansberry Research. For more information on Stansberry, click here.
 
back to top


Q: I'm not receiving my DailyWealth e-mail. What do I do?

A: To ensure DailyWealth does not get blocked by your spam filter, place us on your "whitelist." It's as easy as adding [email protected] to your address book.
back to top


Q: I recently received an investment report from DailyWealth, and now I can't find it. Is it posted online?

A: DailyWealth subscribers can access all our archived investment reports at DailyWealth.com under the section titled "Free Reports."
 
back to top


Q: I recently read a great investment idea in a DailyWealth e-mail, and now I can't find it. Is it posted online?

A: You can find all our essays archived online at DailyWealth.com. You can search our archive for specific words and phrases in the search box on the upper right.
 
back to top


Q: I recently received a newsletter advertisement from DailyWealth and I'd like to learn more. Is there someone I can call?

A: You can contact our publisher's customer service representatives at 1-888-261-2693 for more information.
 
back to top


Q: How do I unsubscribe?

A: To unsubscribe from DailyWealth, click the "unsubscribe" link at the bottom of your DailyWealth e-mail. To unsubscribe from DailyWealth Premium, call customer service at 1-888-261-2693.
 
back to top


Q: I am a new subscriber, why am I receiving DailyWealth?

A: Welcome to DailyWealth! 

You recently signed up for an investment newsletter or a trial subscription at Stansberry Research. As part of your paid subscription, you're entitled to receive our three daily e-letters: The Stansberry Digest (which goes to paid subscribers only), DailyWealth, and Growth Stock Wire. These e-letters complement our newsletters and trading services by providing you with important updates to our recommendations, educational material, and insights into how we approach the markets.

As these e-letters are free, from time to time you will receive advertising for our products and associated products along with the editorial material. However, you are under no obligation to receive these free e-letters or this advertising. To cancel these free e-letters and the associated advertising, simply follow the cancellation instructions at the bottom of the letter. Canceling a free e-letter will not cancel your paid subscription.

To access your paid subscription materials (including all of the back issues) and the special reports included with your purchase, please go to our website: www.stansberryresearch.com. Your paid subscription materials will also be sent to your e-mail address on file as new content is released.
back to top


Q: What is a PSV* Stansberry Research Charge?

A: A PSV* Stansberry Research charge on your credit card statement relates to a Stansberry Research financial newsletter subscription or product. Learn more here.
back to top



About Us | Contributors | Steve's Story | Best Of | FAQ | Contact Us
Legal Notices: Stansberry Research LLC (Stansberry Research) is a publishing company and the indicators, strategies, reports, articles and all other features of our products are provided for informational and educational purposes only and should not be construed as personalized investment advice. Our recommendations and analysis are based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.

 

Readers should be aware that trading stocks and all other financial instruments involves risk. Past performance is no guarantee of future results, and we make no representation that any customer will or is likely to achieve similar results.

 

Our testimonials are the words of real subscribers received in real letters, emails, and other feedback who have not been paid for their testimonials. Testimonials are printed under aliases to protect privacy, and edited for length. Their claims have not been independently verified or audited for accuracy. We do not know how much money was risked, what portion of their total portfolio was allocated, or how long they owned the security. We do not claim that the results experienced by such subscribers are typical and you will likely have different results.

 

Any performance results of our recommendations prepared by Stansberry Research are not based on actual trading of securities but are instead based on a hypothetical trading account. Hypothetical performance results have many inherent limitations. Your actual results may vary.

 

Stansberry Research expressly forbids its writers from having a financial interest in any security they recommend to our subscribers. And all Stansberry Research (and affiliated companies), employees, and agents must wait 24 hours after an initial trade recommendation is published on the Internet, or 72 hours after a direct mail publication is sent, before acting on that recommendation.

 

© 2024 Stansberry Research, LLC. | Privacy Policy| Customer Service
Stansberry Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This website may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry Research, LLC. 1125 N Charles St. Suite 500, Baltimore MD 21202.